Verition Fund Management LLC bought a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 6,031 shares of the company’s stock, valued at approximately $382,000.
Several other hedge funds and other institutional investors also recently made changes to their positions in the business. GAMMA Investing LLC increased its position in shares of Acadia Healthcare by 57.1% during the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after acquiring an additional 241 shares in the last quarter. Blue Trust Inc. increased its position in shares of Acadia Healthcare by 86.1% during the second quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after acquiring an additional 248 shares in the last quarter. Commonwealth Equity Services LLC increased its position in shares of Acadia Healthcare by 3.5% during the second quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock worth $513,000 after acquiring an additional 257 shares in the last quarter. Atria Investments Inc increased its position in shares of Acadia Healthcare by 4.7% during the third quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock worth $434,000 after acquiring an additional 308 shares in the last quarter. Finally, KBC Group NV increased its position in shares of Acadia Healthcare by 14.4% during the third quarter. KBC Group NV now owns 2,688 shares of the company’s stock worth $170,000 after acquiring an additional 338 shares in the last quarter.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on the stock. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and upped their price objective for the stock from $45.00 to $75.00 in a research report on Thursday. KeyCorp assumed coverage on shares of Acadia Healthcare in a research report on Friday, October 11th. They issued a “sector weight” rating for the company. StockNews.com downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Friday, November 22nd. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $52.00 price objective on shares of Acadia Healthcare in a research report on Tuesday. Finally, Barclays reduced their price objective on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research report on Friday, November 22nd. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $75.44.
Acadia Healthcare Stock Up 1.3 %
ACHC opened at $40.34 on Friday. The stock has a market cap of $3.75 billion, a price-to-earnings ratio of 13.23, a PEG ratio of 1.82 and a beta of 1.29. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The company’s 50-day moving average price is $45.69 and its two-hundred day moving average price is $61.98. Acadia Healthcare Company, Inc. has a twelve month low of $36.50 and a twelve month high of $87.77.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. The company had revenue of $815.60 million for the quarter, compared to analysts’ expectations of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. Acadia Healthcare’s revenue was up 8.7% compared to the same quarter last year. During the same period in the prior year, the company posted $0.91 EPS. As a group, equities analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.
Acadia Healthcare Profile
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Recommended Stories
- Five stocks we like better than Acadia Healthcare
- Golden Cross Stocks: Pattern, Examples and Charts
- WallStreetBets: How a Reddit Forum Shook Up Stock Market Dynamics
- Upcoming IPO Stock Lockup Period, Explained
- Are 2024’s Top Insider Buys a Good Bet for 2025?
- ETF Screener: Uses and Step-by-Step Guide
- 4 Social Media Stocks to Soar as TikTok’s Future Hangs in Balance
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.